Facebook
Twitter
LinkedIn
Forward
27th University of Chicago Comprehensive Cancer Center Developmental Therapeutics Symposium
Chicago, IL US
May 10, 2024
Elevate your oncology expertise with this dynamic symposium!
The symposium will empower participants to unlock the full potential of precision medicine in cancer care, resulting in improved patient outcomes. Through this engaging activity, you'll embark on a journey to:
- Analyze Cutting-Edge Data: Delve into curated data from completed studies to gain unique insights.
- Explore Novel Investigational Agents: Discover the latest advancements in ongoing clinical trials, equipping yourself with valuable knowledge on groundbreaking therapies.
- Uncover Research Rationale and Results: Gain a comprehensive understanding of the motivations and findings behind studies involving innovative agents for advanced cancer treatment.
This knowledge is your key to harnessing the power of modern treatments, bolstering support for ongoing oncology trials, and understanding how the latest oncology research can improve your practice.
This symposium is your bridge to mastering precision medicine in oncology, ultimately transforming the lives of cancer patients for the better. Join us in shaping the future of cancer care!
Target Audience
This activity is designed for physicians and other healthcare professionals who diagnose, screen, and treat patients with cancer.
Learning Objectives
After this activity, participants will be able to:
- Identify how to assess patient suitability for participation in ongoing and upcoming cancer clinical trials and projects;
- State the clinical effects of novel immunotherapeutic agents, including but not limited to novel checkpoint inhibitors, bispecific antibodies, and novel cellular therapies;
- Cite the relevant pharmacologic and biologic effects of novel anti-cancer agents through the use of blood and tissue samples as well as standard and novel imaging approaches, including novel PET tracer imaging and circulating tumor DNA assays;
- Describe the current science related to radioligand therapy and available agents;
- Discuss advances in the use of systemic therapies for cancer, including those targeting specific molecular alterations such as DNA repair mutations, specific chromosomal translocations, and tyrosine kinase mutations.
- Assess the status of and developmental pathway for antibody-drug conjugates in solid and hematologic tumors.
You may also be interested in
Session Time | Session Name | Moderator(s) | Speakers |
|---|---|---|---|
8:15 - 8:45 AM | Registration / Breakfast / Exhibits Open | ||
8:45 - 10:05 AM | Welcome Disease 1 - Breast Disease 2 - Lung Cancer Disease 3 - Head and Neck | Walter Stadler, MD | Nan Chen, MD Marina Garassino, MD Ari Rosenberg, MD |
10:05 - 10:25 AM | Break / Visit Exhibits | ||
10:25 AM - 12:05 PM | Disease 4 - Myeloma Disease 5 - Gastrointestinal Disease 5 - Lymphoma Disease 7 - Leukemia: Progress in ALL and AML | Toyosi Odenike, MD | Benjamin Derman, MD Joseph Franses, MD, PhD Justin Kline, MD Anand Patel, MD |
12:05 - 1:05 PM | Lunch / Lunchtime Breakouts | ||
12:20 - 1:05 PM | *Concurrent Lunchtime Breakouts: | ||
1. Internal Research Staff / Nurses | Lauren Wall | Livia Szeto Sara Moellering Lauren Wall | |
2. Physicians | Walter Stadler, MD | Mark Ratain, MD | |
1:05 - 1:20 PM | Break / Visit Exhibits | ||
1:20 - 2:35 PM | Disease 8 - Cellular Therapy in Solid Tumors Disease 9 - Gynecologic Disease 10 - Prostate | Toyosi Odenike, MD | Dan Olson, MD Diane Yamada, MD Russ Szmulewitz, MD |
2:35 - 2:40 PM | Closing Remarks | Toyosi Odenike, MD | Walter Stadler, MD Toyosi Odenike, MD |
2:40 PM | Adjourn | ||
2:40 - 3:40 PM | Trainees (Residents & Fellows) Post-Conference Reception: Developing a Career in Clinical Research | Walter Stadler, MD Toyosi Odenike, MD |
*The agenda is subject to change.
David Rubenstein Forum at the University of Chicago
1201 E 60th St
Chicago, IL
60637
United States
DAVID RUBENSTEIN FORUM
The David Rubenstein Forum combines a variety of spaces, both formal and informal, large and small, calm and animated, focused and diffuse, scheduled and spontaneous. Its ten-story tower features vibrant and distinct “neighborhoods.” For example, the third and fourth floors are home to Friedman Hall, a 285-seat auditorium optimized for spoken word, including keynote speeches, invited-speaker addresses, and select performances; these floors and other neighborhoods are connected by a two-story lounge. Meeting rooms on the eighth and ninth floors feature premium furnishings, finishes, and equipment, such as the Peter May Boardroom, a tiered meeting space that seats over 70. The Rubenstein Forum’s unique position on the Midway allows for expansive views toward the campus and surrounding communities as well as downtown Chicago and Lake Michigan.
WANT TO KNOW MORE?
Visit the David Rubenstrein Forum's website! For more information about the program, contact Meeting Achievements via e-mail.
VISITING CHICAGO
Discover why Condé Nast Traveler readers voted Chicago the Best Big City in the U.S. for a historic sixth year in a row. To help plan your stay in Chicago, visit choosechicago.com.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 219-465-1115 or via email at support@meetingachievements.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO COURSE DIRECTORS
Walter M. Stadler, MDFred C. Buffett Professor of Medicine and Surgery
Dean for Clinical Research
Senior Advisor to Comprehensive Cancer Center Director
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 5.25 contact hours.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
EXHIBIT OPPORTUNITIES ARE AVAILABLE!
This conference offers a tremendous opportunity to highlight your company's products, services, and achievements in front of a wide array of key decision-makers. Increase your company profile by participating as an exhibitor at this exciting event.
We are pleased to provide opportunities for organizations to advertise their products and services to symposium participants. Whether you are displaying your products in the exhibit space, interacting with physicians during a break, or gaining brand recognition for your company through program acknowledgments, your message will reach physicians, nurses, and other healthcare professionals.
Download the prospectus 
here or contact Meeting Achievements at support@meetingachievements.com or (219) 465-1115. We hope to see you there!
here or contact Meeting Achievements at support@meetingachievements.com or (219) 465-1115. We hope to see you there!
REGISTRATION
After logging in/creating an account, select your registration type below and click "Register Now!" Simply follow the prompts to complete your registration.
| Profession Type | Fee |
|---|---|
| Physician | $50 |
| Healthcare Professional | $25 |
| Trainee | $25 |
| Industry | $350 |
| CANCELLATION POLICY: If you cancel your participation in this conference, your registration fee less a 50% administrative fee will be refunded when written notification is received by April 10, 2024. No refunds will be made after April 10, 2024. | |
CLAIMING CREDIT
At the end of the activity, the credit-claiming process will unlock. Return to this page and click on "Complete Activity" to proceed.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
Please login or create an account to proceed.